About
Vitamed is a generic pharmaceutical manufacturer and part of Rekah Pharmaceutical Industries, an Israeli public company traded on the Tel Aviv Stock Exchange (REKA). Vitamed, along with other subsidiaries (Ophir & Shalpharm, Tree of Life, Moraz), is involved in the manufacturing, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins, nutritional supplements, and innovative medical devices. The Rekah Group is active across the entire value chain, including production, R&D, marketing, sales, distribution, import, and export. Vitamed focuses on increasing its international presence through out-licensing, in-licensing, new partnerships, and mergers and acquisitions. The company's portfolio includes a wide range of generic prescription and over-the-counter drugs, dermo-cosmetics, vitamins, and nutritional supplements, with a focus on steroids, antibiotics, ophthalmic medications, and over-the-counter drugs. Production takes place at sites in Holon and Binyamina, Israel. Rekah Pharmaceutical Industries Ltd. was founded in 1941. The company has approximately 495 employees.
Headcount over time
Offices
Q&A
- What is Vitamed, Rekah Group's primary business?
- Vitamed, Rekah Group is a generic pharmaceutical manufacturer that is part of Rekah Pharmaceutical Industries. The group is involved in production, R&D, marketing, sales, distribution, import, and export of a wide range of generic prescription and over-the-counter drugs, dermo-cosmetics, vitamins, and nutritional supplements.
- When was Vitamed, Rekah Group founded?
- Vitamed, Rekah Group was founded in January 1947.
- What is the current employee count for Vitamed, Rekah Group?
- Vitamed, Rekah Group has 11-50 employees.
- What is Vitamed, Rekah Group's current market capitalization?
- Vitamed, Rekah Group has a market capitalization of $39,614,194 USD.
- What are the core focus areas for Vitamed, Rekah Group's product portfolio?
- The company's product portfolio focuses on four core fields: steroids, antibiotics, ophthalmic medications, and over-the-counter drugs.
- Where are Vitamed, Rekah Group's research and development laboratories located?
- The group operates research and development laboratories at its production sites in Holon and Binyamina, Israel.
- What is Vitamed's strategy for increasing its international presence?
- Vitamed is working to increase its international presence by focusing on out-licensing, in-licensing, establishing new partnerships, and executing mergers and acquisitions.
- Who is the General Manager at Vitamed, Rekah Group?
- Jack Azran serves as the General Manager at Vitamed, Rekah Group.
Team · 15
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | rekah.co.il |
|---|---|
| linkedin.com/company/19016127 |
Identifiers & details
| Legal name | Rekah Pharmaceutical Industry Ltd. |
|---|---|
| Founded | 1941 |
| Employees (exact) | 495 |
| Market cap | $39.6M |
| Status reason | Public on TASE on Jan, 1994; |
Radar intelligence
Web history (Wayback)
| Domain | rekah.co.il |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 520042003 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה ציבורית |
| Incorporated | 1993-08-24 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2012 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | המלאכה 30 חולון |